Ashok Leyland
BSE SENSEX
34,427
S&P CNX
10,565
19 April 2018
Update
| Sector:
Automobiles
CMP: INR151
TP: INR179(+19%)
Buy
Multiple drivers to ensure a smooth ride
Management reiterates focus on LCVs, exports, defence, digital initiatives
Stock Info
Bloomberg
Equity Shares (m)
52-Week Range (INR)
1, 6, 12 Rel. Per (%)
M.Cap. (INR b)
M.Cap. (USD b)
Avg Val, INRm
Free float (%)
AL IN
2,927
153 / 81
-1/11/69
442
6.7
1606.0
48.7
Financials Snapshot (INR b)
2018E 2019E 2020E
Y/E Mar
Net Sales
260.4 308.0 360.6
EBITDA
28.4
35.6
42.8
PAT
15.9
21.2
26.9
EPS (INR)
5.4
7.2
9.2
Gr. (%)
28.8
33.1
27.1
BV/Sh (INR)
23.9
28.5
34.7
RoE (%)
24.3
27.6
29.2
RoCE (%)
20.3
23.3
25.2
P/E (x)
27.8
20.9
16.4
P/BV (x)
6.3
5.3
4.4
Shareholding pattern (%)
As On
Mar-18 Dec-17 Mar-17
Promoter
45.5
51.3
50.4
DII
11.8
11.5
9.9
FII
26.4
22.6
17.9
Others
16.3
14.6
21.9
FII Includes depository receipts
Stock Performance (1-year)
Ashok Leyland
Sensex - Rebased
150
130
110
90
70
We attended Ashok Leyland’s (AL) Annual Global Conference 2018. Themed ‘Conquer
new
frontiers – More battles to win,’
the conference provided useful insights into the
company’s operations and opportunities. Management re-iterated its focus on gaining
further ground in LCVs, exports, defence and digital initiatives (after-sales and service
infrastructure). Encouragingly, AL’s product launch pipeline remains strong, with five
products planned to be rolled out in the M&HCV segment and two products each in the
LCV and bus segments. The company also targets to launch a new variant of Dost in the
LCV segment. Furthermore, AL is sanguine about the FY19 demand outlook, considering
the pick-up in mining and infrastructure activities. Pre-buy demand ahead of the BS-6
emission standards implementation is another positive.
Key highlights of the conference
Outlook remains positive; new product launch pipeline robust
M&HCV industry growth momentum is expected to continue until FY20. The
new product launch pipeline remains robust, with around nine new products
planned for roll out in FY19. AL expects the shift toward higher-tonnage
vehicles to continue until FY20.
AL is expected to continue expanding its market share this year, led by network
expansion (~35% expansion in FY18 for M&HCVs and ~20% for LCVs) and new
product launches.
Robust growth in exports is attributed to healthy sales in Nepal, Bangladesh,
the Middle East and ASEAN markets. The company targets to reach an exports
market share of 50% in 3-5 years (v/s <35% currently of exports from India).
The company’s focus on quality improvement, sales and customer satisfaction
is resulting in industry leading performance across parameters.
Spare parts business grew at a 30% CAGR in the last two years to reach a size of
INR12.6b in FY18.
It would invest INR10b in FY19, largely towards building capabilities in areas
like product development, engines, modular program and cabins.
AL expects M&HCV industry volumes to grow 10% in FY19, driven by infra,
construction & mining, and rigorous implementation of rated load in other
markets. Tippers segment is expected to see good growth in FY19, along with
continued momentum in MAV and tractor trailers.
For FY20, AL expects significant pre-buying ahead of BS6 implementation from
April 2020.
AL is expected to continue expanding its market share this year, led by network
expansion and new product launches. AL’s M&HCV sales network grew 4x to
2,894 outlets in FY18 (~35% expansion in FY18 for M&HCVs) from 689 outlets
in FY14. LCV network grew to 465 outlets in FY18 from 300 outlets in FY14
(~20% for LCVs).
Jinesh Gandhi - Research analyst
(Jinesh@MotilalOswal.com); +91 22 6129 1524
Research analyst: Deep Shah
(Deep.S@MotilalOswal.com); +91 22 61291533/
Suneeta Kamath
(Suneeta.Kamath@MotilalOswal.com); +91 22 61291534
Motilal Oswal research is available on www.motilaloswal.com/Institutional-Equities, Bloomberg, Thomson Reuters, Factset and S&P Capital.
Investors are advised to refer through important disclosures made at the last page of the Research Report.

Ashok Leyland
Targets exports market share of 50% in 3-5 years
In the M&HCV segment, the company plans to launch several new products in
FY19, such as (i) Captain 2532 (320HP truck for deep mining application;
intended to compete against segment leader MAN Trucks), (ii) 4123 haulage
truck (thus creating a new segment), (iii) 4932 tractor trailer, (iv) Boss 1616
(with driver rest cabin – first-ever in the segment), and Guru 1010 (gap filler in
the AL product portfolio).
In LCVs, AL is targeting the launch of Dost Express and new facelift of Dost.
In the bus segment, AL plans to launch MiTR panel van, Alpha, Falcon, Lynx
Strong, Eco School bus (sunshine variant), and Freedom, among others.
According to management, growth in exports was led by healthy sales in the key
markets of Bangladesh, Nepal, the Middle East, and other SAARC and ASEAN
countries.
AL targets exports market share of at least 50%, and is planning to launch
several new LHD (left hand drive) products (like Partner and Dost LHD) in the
high-potential markets like ASEAN.
Furthermore, recent network expansion in key overseas markets like Dubai,
Ivory Coast, Nepal and Kenya is expected to boost volumes in these markets.
AL has received robust response to its digital marketplace platform ‘Service
Mandi,’ with ~4k+ mechanics already on board in key routes of Delhi-Mumbai-
Chennai-Kolkata.
The company recorded revenue of ~INR1b from this platform within six months
of launch (till Mar-18). It has average transaction value of INR4k.
AL plans pan-India rollout of Service Mandi to tap the after-sales and spare parts
business opportunity.
Robust response to Service Mandi platform; ~4k+ mechanics on board
Focus on quality improvement, sales and customer satisfaction drives
industry best performance
FY19 capex at INR10b, 60% attributed to build capabilities
With its continued focus on quality and product improvement, AL has managed
to achieve defects per vehicle (DPV) of 0.2 in FY18 (v/s 7.8 DPV in 1QFY12).
Similarly, it has persistently improved the customer satisfaction index (CSI),
which stood at 741 in FY18 (competitor average: 692).
AL’s sales satisfaction index increased to 817 in FY18 (competitor average: 787).
AL is not targeting capacity addition in any segment, except for a small bus plant
in Vijayawada to meet the bus body code requirements.
However, it is focused on building capabilities in areas like product
development, engines, modular program and cabins.
It would be incurring capex of INR10b in FY19. It doesn’t foresee any material
investments in subsidiaries in FY19.
‘Consumer solution’ will be a new business vertical to tap the after-sales
opportunities.
AL’s spare parts revenue grew at a 30% CAGR over FY16-18 to INR12.63b.
Currently, ~30% of buses plying on road follow bus body code norms.
AL manufactures ~400 bus bodies per month.
It plans to reduce focus on the low-margin SCV business.
Truck travel is 8-10k kilometer per month and has life of ~1m km.
2
Other takeaways
19 April 2018

Ashok Leyland
Valuation and view
We expect growth momentum in CV demand to continue in FY19-20, driven by a
pick-up in infra, construction and mining activities. Furthermore, mandatory
scrapping of trucks should benefit CV demand.
AL’s focus on new growth areas by increasing the share of LCVs, exports, spare
parts and defense should drive strong revenue CAGR of 21.7% over FY17-20.
With a recovery in demand, ramp-up in newer focus areas and cost-reduction
measures, EBITDA margin is expected to gradually improve to 11.9% by FY20.
The stock trades at 8x FY20 EV/EBITDA and ~15.8x FY20 standalone EPS.
We value AL at ~INR179 (10x March 2020E EV/EBITDA + ~INR13/share for stake
in HLF post 20% HoldCo discount). Maintain
Buy.
Exhibit 2: Robust growth in LCV network too
LCV network
465
2894
2154
300
328
342
387
Exhibit 1: M&HCV sales network grew 4x in FY14-18
M&HCV network
689
FY14
780
1164
FY15
FY16
FY17
FY18
FY14
FY15
FY16
FY17
FY18
Source: Company, MOSL
Source: Company, MOSL
Exhibit 3: Industry best CSI backed by focus on product
improvement
Customer satisfaction index
741
690
650
658
Exhibit 4: Industry best SSI
Sales satisfaction index
817
781
747
757
FY15
FY16
FY17
FY18
FY15
FY16
FY17
FY18
Source: Company, MOSL
Source: Company, MOSL
Exhibit 5: Persistent improvement in DPV
Defects per vehicle (DPV)
7.8
Exhibit 6: Spare parts revenue CAGR of 30% over FY16-20
Spare parts revenue (INR bn)
12.63
9.68
7.47
0.67
1QFY12 FY13
0.38
FY14
0.42
FY15
0.29
FY16
0.20
FY17
0.20
FY18
FY16
FY17
FY18
Source: Company, MOSL
Source: Company, MOSL
19 April 2018
3

Ashok Leyland
Exhibit 7: Snapshot of revenue model
000 units
HCV Passenger (units)
Growth (%)
HCV Goods (units)
Growth (%)
LCVs (units)
Growth (%)
DOST (units)
Growth (%)
Non-DOST JV (units)
Growth (%)
Total volumes ex Dost (units)
Growth (%)
Total Volumes incl Dost (units)
Growth (%)
ASP (INR '000/unit)
Growth (%)
Net Sales (INR b)
Growth (%)
FY15
21
7.7
57
39.0
2
306.0
25
-9.7
0
-0.5
79
30.9
105
17.4
1,293
16.1
136
36.4
FY16
26
24.1
84
47.6
1
-13.1
29
14.1
0
0.3
111
40.2
140
33.8
1,349
4.4
189
39.6
FY17
23
-12.1
91
7.9
0
-89.3
31
8.3
0
0.3
113
2.0
145
3.4
1,380
2.3
200
5.7
FY18E
21
-12.0
111
22.0
8
4,784.6
35
12.0
1
1.0
139
22.6
175
20.5
1,489
7.9
260
30.1
FY19E
22
8.0
124
12.0
14
80.0
37
5.0
1
0.5
160
15.1
198
13.3
1,555
4.4
308
18.3
FY20E
24
8.0
139
12.0
19
35.0
39
5.0
2
0.3
182
13.4
222
12.0
1,626
4.6
361
17.1
Source: MOSL, Company
Exhibit 8: Comparative valuation
CMP
Auto OEM's
Bajaj Auto
2,855
Hero MotoCorp
3,729
TVS Motor
675
M&M
803
Maruti Suzuki
9,077
Tata Motors
335
Ashok Leyland
151
Eicher Motors
30,903
Auto Ancillaries
Bharat Forge
750
Exide Industries
244
Amara Raja Batteries 844
BOSCH
19,521
Endurance Tech
1,330
Motherson Sumi
347
Mahindra CIE
233
Rating
TP
(INR)
P/E (x)
FY19E
17.0
18.5
30.1
17.1
26.0
6.0
20.9
29.6
28.4
24.7
24.8
33.5
34.8
27.7
19.1
EV/EBITDA (x)
FY19E
12.3
11.3
18.1
13.6
16.5
2.7
10.8
24.6
16.4
14.2
12.7
19.8
16.9
10.1
9.9
RoE (%)
FY19E
24.6
32.2
32.0
14.8
21.8
23.9
27.6
35.5
23.3
14.0
18.0
17.5
23.8
25.4
11.7
Div Yield (%)
FY19E
2.6
2.5
0.6
1.2
1.2
0.1
1.5
0.6
0.7
0.9
0.6
1.0
0.5
0.9
0.0
(INR)*
Buy
Neutral
Neutral
Buy
Buy
Buy
Buy
Buy
Buy
Buy
Buy
Neutral
Buy
Buy
Buy
FY20E
14.5
16.8
20.9
15.7
20.1
5.8
16.4
23.0
21.6
20.1
21.1
28.1
26.1
19.9
15.3
FY20E
10.1
10.2
12.9
12.0
13.0
2.4
8.4
19.8
13.1
11.8
10.7
16.6
13.4
7.2
8.0
FY20E
26.0
30.9
35.1
15.2
24.0
19.8
29.2
34.2
25.4
15.3
18.3
18.7
26.4
29.3
12.9
EPS CAGR
(%)
FY20E FY18-20E
3.0
2.8
0.7
1.2
1.5
0.1
1.7
0.6
0.8
1.3
0.7
1.2
1.0
1.4
0.0
15.5
9.1
51.3
13.5
28.2
52.8
30.1
28.5
31.9
22.9
19.0
23.0
35.2
47.0
25.8
Source: MOSL
3,550
3,922
710
889
10,560
523
179
34,772
869
286
1,000
19,096
1,531
437
274
19 April 2018
4

Ashok Leyland
Ashok Leyland | Story in Charts: Best play on CV cycle recovery
Exhibit 9: AL continues to grow market share…
M&HCV Dom. Market Share (%)
32.7
28.7
25.7
23.6
105
FY11
FY12
FY13
FY14
FY15
FY16
FY17
FY18
FY15
140
FY16
145
FY17
175
FY18E
198
FY19E
222
FY20E
26.1
25.7
33.8
34.2
1,293
Exhibit 10: …without diluting pricing
Total volume (units)
1,349
1,380
1,489
ASP (INR '000/unit)
1,555
1,626
Source: Company, MOSL
Source: Company, MOSL
Exhibit 11: Revenue to grow at 21.7% CAGR over FY17-20
Revenues (INR m)
36.4
(3.3)
(20.3)
200,187
124,812
FY13
135,622
99,434
FY14
FY15
189,373
FY16
FY17
260,390
FY18E
FY19E
360,615
FY20E
307,951
39.6
5.7
Growth (%)
30.1
18.3
17.1
Exhibit 12: Margins to gradually improve over FY17-20
EBITDA (INR b)
11.9
7.0
1.7
7.6
11.0
EBITDA Margins (%)
10.9
11.6
11.9
8,765
FY13
1,666 10,266 22,546 22,026 28,392 35,599 42,804
FY14
FY15
FY16
FY17
FY18E FY19E FY20E
Source: Company, MOSL
Source: Company, MOSL
Exhibit 13: Capex/investments to moderate significantly
CFO
Capex (incl Invest)
27
19 21
18
18
4
1
25
10
-15
FY17
26
1
35
-7
FCF
33
40
-7
Exhibit 14: Focused on reducing debt levels
43
47
Net debt (INR b)
15
25
32
28
4
-4
-14
-33
-56
8
-12
-4
FY13
5
-1
6
FY14
FY15
FY16
FY18E FY19E FY20E
Source: Company, MOSL
FY11 FY12 FY13 FY14 FY15 FY16 FY17 FY18E FY19E FY20E
Source: Company, MOSL
19 April 2018
5

Ashok Leyland
Financials and Valuations
Income Statement
Y/E March
Volumes ('000 units)
Growth (%)
Net Sales
Change (%)
EBITDA
Change (%)
EBITDA Margins (%)
Depreciation
EBIT
Interest & Fin. Charges
Other Income
PBT
Tax
Effective Rate (%)
Rep. PAT
Change (%)
% of Net Sales
Adjusted PAT
Change (%)
2013
115
11.5
124,812
-3.3
8,765
-33.5
7.0
3,808
4,957
3,769
624
4,707
370
7.9
4,337
-30.9
-30.9
1,669
-73.3
2013
2,661
41,890
44,551
43,554
5,274
-
93,379
2014
89
-22.1
99,434
-20.3
1,666
-81.0
1.7
3,770
-2,105
4,529
665
-912
(1,206)
132.2
294
-93.2
-93.2
-4,763
-385.4
2014
2,661
41,818
44,479
46,903
4,068
-
95,450
2015
105
17.4
135,622
36.4
10,266
516.4
7.6
4,163
6,103
3,935
1,245
4,422
1,074
24.3
3,348
1,039.6
1,039.6
2,339
-149.1
2015
2,846
49,002
51,848
22,953
2,861
-
77,662
2016
140
33.8
189,373
39.6
22,546
119.6
11.9
4,879
17,667
2,476
1,176
8,215
4,369
53.2
3,845
14.8
14.8
11,998
413.0
2016
2,846
51,226
54,071
20,201
3,291
-
77,563
2017
145
3.4
200,187
5.7
22,026
-2.3
11.0
5,179
16,847
1,554
1,363
13,147
1,070
8.1
12,077
214.1
214.1
12,360
3.0
2017
2,927
58,334
61,261
13,450
1,269
-
75,979
2018E
175
20.5
260,390
30.1
28,392
28.9
10.9
5,489
22,904
1,467
1,700
23,011
7,162
31.1
15,849
31.2
31.2
15,919
28.8
2018E
2,927
67,086
70,013
18,450
2,417
-
90,879
2019E
198
13.3
307,951
18.3
35,599
25.4
11.6
6,140
29,459
1,595
2,725
30,589
9,406
30.7
21,183
33.7
33.7
21,183
33.1
2019E
(INR Million)
2020E
222
12.0
360,615
17.1
42,804
20.2
11.9
6,596
36,208
1,345
3,750
38,613
11,680
30.3
26,932
27.1
27.1
26,932
27.1
2020E
Balance Sheet
Y/E March
Sources of Funds
Share Capital
Reserves
Net Worth
Loans
Deferred Tax Liability
Foreign currency translation
Capital Employed
Application of Funds
Gross Fixed Assets
Less: Depreciation
Net Fixed Assets
Capital WIP
Investments
Curr.Assets, L & Adv.
Inventory
Sundry Debtors
Cash & Bank Balances
Loans & Advances
Current Liab. & Prov.
Sundry Creditors
Other Liabilities
Provisions
Net Current Assets
Application of Funds
(INR Million)
2,927
80,347
83,274
13,450
3,946
-
100,670
2,927
98,478
101,405
13,450
5,877
-
120,731
83,796
25,588
58,208
6,889
23,376
47,883
18,960
14,194
139
14,589
37,588
24,854
8,862
3,872
10,295
98,769
86,723
30,124
56,599
1,815
27,897
41,769
11,887
12,990
117
16,775
32,630
22,142
8,929
1,560
9,139
95,450
49,871
5,600
44,271
1,201
26,967
59,308
12,427
7,262
7,722
31,898
54,087
28,283
22,457
3,347
5,222
77,662
53,659
4,859
48,800
759
19,804
60,992
16,250
12,511
15,931
16,299
52,791
25,627
24,046
3,119
8,201
77,563
59,807
8,871
50,937
2,059
28,789
56,210
25,011
8,601
9,120
13,479
62,015
30,522
25,324
6,169
(5,804)
75,979
66,366
14,359
52,007
1,500
22,017
86,603
28,536
15,695
32,384
9,988
71,247
35,670
26,396
9,181
15,356
90,879
71,616
20,499
51,116
1,250
23,517
108,641
33,748
16,874
46,207
11,812
83,854
42,185
31,217
10,453
24,786
100,670
76,616
27,096
49,520
1,250
25,017
142,664
39,519
19,760
69,554
13,832
97,720
49,399
36,555
11,766
44,944
120,731
19 April 2018
6

Ashok Leyland
Financials and Valuations
Ratios
Y/E March
Basic (INR)
EPS
EPS Fully Diluted
EPS Growth (%)
Cash EPS
Book Value per Share
DPS
Payout (Excl. Div. Tax) %
Valuation (x)
P/E
Cash P/E
EV/EBITDA
EV/Sales
Price to Book Value
Dividend Yield (%)
Profitability Ratios (%)
ROE
RoCE
RoIC
Turnover Ratios
Debtors (Days)
Inventory (Days)
Creditors (Days)
Working Capital (Days)
Fixed-Asset Turnover (x)
Leverage Ratio
Debt/Equity (x)
2013
0.6
0.6
-73.3
2.1
16.7
0.6
95.6
240.8
73.4
50.8
3.6
9.0
0.4
3.9
5.9
7.5
42
55
73
24
2.1
1.0
2013
4,707
264
3,808
-1,100
-350
218
7,547
0
7,547
-6,438
1,109
-11,907
11,004
-3,742
-3,092
4,170
-190
241
52
2014
-1.8
-1.8
-385.4
-0.4
16.7
0.0
0.0
-84.4
-405.0
269.4
4.5
9.0
0.0
-10.7
0.5
1.1
48
44
81
10
1.8
1.1
2014
-912
220
3,789
-297
3,701
-495
6,005
0
6,005
-2,071
3,935
-1,102
1,827
-4,446
-1,868
-4,486
417
52
469
2015
0.8
0.8
-145.9
2.3
18.2
0.45
54.8
183.8
66.1
43.4
3.3
8.3
0.3
4.9
6.4
8.6
20
33
76
-23
3.1
0.4
2015
4,422
290
4,182
-502
7,049
2,906
18,347
0
18,347
-2,059
16,288
1,015
-14,239
-4,219
0
-11,791
7,571
469
8,040
2016
4.2
4.2
412.9
5.9
19.0
1.0
23.7
35.8
25.5
19.3
2.3
8.0
0.7
22.7
11.4
20.0
24
31
49
6
3.9
0.4
2016
11,692
485
4,489
-4,409
-1,276
6,818
17,800
0
17,800
441
18,241
3,618
-7,886
-2,679
-1,541
-12,107
9,311
8,040
17,352
2017
4.2
4.2
0.2
6.0
20.9
1.6
36.9
35.8
25.2
19.9
2.2
7.2
1.0
21.4
21.8
40.2
16
46
56
6
3.9
0.2
2017
16,847
690
5,179
-3,476
1,903
3,914
25,056
-3,508
21,548
-3,660
17,888
-14,768
-8,827
-1,638
-3,254
-13,719
-6,939
17,352
10,413
2018E
5.4
5.4
28.8
7.3
23.9
2.0
36.8
27.8
20.6
15.1
1.6
6.3
1.3
24.3
20.3
44.4
22
40
50
12
5.0
0.3
2018E
22,904
1,700
5,489
-6,014
2,105
0
26,183
-126
26,057
-6,000
20,057
772
5,000
-1,467
-7,041
-3,509
23,320
10,413
33,733
2019E
7.2
7.2
33.1
9.3
28.5
2.3
31.1
20.9
16.2
11.5
1.3
5.3
1.5
27.6
23.3
63.1
20
40
50
10
6.0
0.2
2019E
29,459
2,725
6,140
-7,877
4,392
0
34,839
0
34,839
-5,000
29,839
-6,500
-5,000
-1,595
-7,921
-14,516
13,823
33,733
47,555
2020E
9.2
9.2
27.1
11.5
34.7
2.5
27.2
16.4
13.2
9.0
1.1
4.4
1.7
29.2
25.2
92.5
20
40
50
10
7.3
0.1
2020E
36,208
3,750
6,596
-9,750
3,189
0
39,993
Cash Flow Statement
Y/E March
OP/(Loss) before Tax
Interest/Dividends Received
Depreciation & Amortization
Direct Taxes Paid
(Inc)/Dec in Working Capital
Other Items
CF from Oper. Activity
Extra-ordinary Items
CF after EO Items
(Inc)/Dec in FA+CWIP
Free Cash Flow
CF from Inv. Activity
Inc/(Dec) in Debt
Interest Rec./(Paid)
Dividends Paid
CF from Fin. Activity
Inc/(Dec) in Cash
Add: Beginning Balance
Closing Balance
(INR Million)
0
39,993
-5,000
34,993
-6,500
0
-1,345
-8,802
-10,147
23,347
47,555
70,902
19 April 2018
7

Explanation of Investment Rating
Investment Rating
BUY
SELL
NEUTRAL
UNDER REVIEW
NOT RATED
Expected return (over 12-month)
>=15%
< - 10%
> - 10 % to 15%
Rating may undergo a change
We have forward looking estimates for the stock but we refrain from assigning recommendation
Ashok Leyland
*In case the recommendation given by the Research Analyst becomes inconsistent with the investment rating legend, the Research Analyst shall within 28 days of the inconsistency, take appropriate measures to make the recommendation consistent with the investment rating legend.
NOTES
Disclosures:
The following Disclosures are being made in compliance with the SEBI Research Analyst Regulations 2014 (herein after referred to as the Regulations).
Motilal Oswal Securities Ltd. (MOSL) is a SEBI Registered Research Analyst having registration no. INH000000412. MOSL, the Research Entity (RE) as defined in the Regulations, is engaged in the business of providing Stock broking services,
Investment Advisory Services, Depository participant services & distribution of various financial products. MOSL is a subsidiary company of Motilal Oswal Financial Service Ltd. (MOFSL). MOFSL is a listed public company, the details in respect of
which are available on
www.motilaloswal.com.
MOSL is registered with the Securities & Exchange Board of India (SEBI) and is a registered Trading Member with National Stock Exchange of India Ltd. (NSE) and Bombay Stock Exchange Limited
(BSE), Metropolitan Stock Exchange Of India Ltd. (MSE) for its stock broking activities & is Depository participant with Central Depository Services Limited (CDSL) & National Securities Depository Limited (NSDL) and is member of Association of
Mutual Funds of India (AMFI) for distribution of financial products. Details of associate entities of Motilal Oswal Securities Limited are available on the website at
http://onlinereports.motilaloswal.com/Dormant/documents/Associate%20Details.pdf
MOSL, it’s associates, Research Analyst or their relative may have any financial interest in the subject company. MOSL and/or its associates and/or Research Analyst may have beneficial ownership of 1% or more securities in the subject company at
the end of the month immediately preceding the date of publication of the Research Report.
MOSL and its associate company(ies), their directors and Research Analyst and their relatives may; (a) from time to time, have a long or short position in, act
as principal in, and buy or sell the securities or derivatives thereof of companies mentioned herein. (b) be engaged in any other transaction involving such securities and earn brokerage or other compensation or act as a market maker in the financial
instruments of the company(ies) discussed herein or act as an advisor or lender/borrower to such company(ies) or may have any other potential conflict of interests with respect to any recommendation and other related information and opinions.;
however the same shall have no bearing whatsoever on the specific recommendations made by the analyst(s), as the recommendations made by the analyst(s) are completely independent of the views of the associates of MOSL even though there
might exist an inherent conflict of interest in some of the stocks mentioned in the research report.
Research Analyst may have served as director/officer, etc. in the subject company in the last 12 month period. MOSL and/or its associates may have
received any compensation from the subject company in the past 12 months.
In the last 12 months period ending on the last day of the month immediately preceding the date of publication of this research report, MOSL or any of its associates may have:
a)
managed or co-managed public offering of securities from subject company of this research report,
b)
received compensation for investment banking or merchant banking or brokerage services from subject company of this research report,
c)
received compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company of this research report.
d)
Subject Company may have been a client of MOSL or its associates during twelve months preceding the date of distribution of the research report.
MOSL and it’s associates have not received any compensation or other benefits from the subject company or third party in connection with the research report. To enhance transparency, MOSL has incorporated a Disclosure of Interest Statement in
this document. This should, however, not be treated as endorsement of the views expressed in the report. MOSL and / or its affiliates do and seek to do business including investment banking with companies covered in its research reports. As a result,
the recipients of this report should be aware that MOSL may have a potential conflict of interest that may affect the objectivity of this report. Compensation of Research Analysts is not based on any specific merchant banking, investment banking or
brokerage service transactions.
Terms & Conditions:
This report has been prepared by MOSL and is meant for sole use by the recipient and not for circulation. The report and information contained herein is strictly confidential and may not be altered in any way, transmitted to, copied or distributed, in part
or in whole, to any other person or to the media or reproduced in any form, without prior written consent of MOSL. The report is based on the facts, figures and information that are considered true, correct, reliable and accurate. The intent of this report
is not recommendatory in nature. The information is obtained from publicly available media or other sources believed to be reliable. Such information has not been independently verified and no guaranty, representation of warranty, express or implied,
is made as to its accuracy, completeness or correctness. All such information and opinions are subject to change without notice. The report is prepared solely for informational purpose and does not constitute an offer document or solicitation of offer to
buy or sell or subscribe for securities or other financial instruments for the clients. Though disseminated to all the customers simultaneously, not all customers may receive this report at the same time. MOSL will not treat recipients as customers by
virtue of their receiving this report.
Analyst Certification
The views expressed in this research report accurately reflect the personal views of the analyst(s) about the subject securities or issues, and no part of the compensation of the research analyst(s) was, is, or will be directly or indirectly related to the
specific recommendations and views expressed by research analyst(s) in this report.
Disclosure of Interest Statement
Analyst ownership of the stock
Ashok Leyland
No
A graph of daily closing prices of securities is available at
www.nseindia.com, www.bseindia.com.
Research Analyst views on Subject Company may vary based on Fundamental research and Technical Research. Proprietary trading desk of MOSL or
its associates maintains arm’s length distance with Research Team as all the activities are segregated from MOSL research activity and therefore it can have an independent view with regards to subject company for which Research Team have
expressed their views.
Regional Disclosures (outside India)
This report is not directed or intended for distribution to or use by any person or entity resident in a state, country or any jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subject
MOSL & its group companies to registration or licensing requirements within such jurisdictions.
For Hong Kong:
This report is distributed in Hong Kong by Motilal Oswal capital Markets (Hong Kong) Private Limited, a licensed corporation (CE AYY-301) licensed and regulated by the Hong Kong Securities and Futures Commission (SFC) pursuant to the Securities
and Futures Ordinance (Chapter 571 of the Laws of Hong Kong) “SFO”. As per SEBI (Research Analyst Regulations) 2014 Motilal Oswal Securities (SEBI Reg No. INH000000412) has an agreement with Motilal Oswal capital Markets (Hong Kong)
Private Limited for distribution of research report in Hong Kong. This report is intended for distribution only to “Professional Investors” as defined in Part I of Schedule 1 to SFO. Any investment or investment activity to which this document relates is only
available to professional investor and will be engaged only with professional investors.” Nothing here is an offer or solicitation of these securities, products and services in any jurisdiction where their offer or sale is not qualified or exempt from
registration. The Indian Analyst(s) who compile this report is/are not located in Hong Kong & are not conducting Research Analysis in Hong Kong.
For U.S.
Motilal Oswal Securities Limited (MOSL) is not a registered broker - dealer under the U.S. Securities Exchange Act of 1934, as amended (the"1934 act") and under applicable state laws in the United States. In addition MOSL is not a registered
investment adviser under the U.S. Investment Advisers Act of 1940, as amended (the "Advisers Act" and together with the 1934 Act, the "Acts), and under applicable state laws in the United States. Accordingly, in the absence of specific exemption
under the Acts, any brokerage and investment services provided by MOSL, including the products and services described herein are not available to or intended for U.S. persons. This report is intended for distribution only to "Major Institutional
Investors" as defined by Rule 15a-6(b)(4) of the Exchange Act and interpretations thereof by SEC (henceforth referred to as "major institutional investors"). This document must not be acted on or relied on by persons who are not major institutional
investors. Any investment or investment activity to which this document relates is only available to major institutional investors and will be engaged in only with major institutional investors. In reliance on the exemption from registration provided by Rule
15a-6 of the U.S. Securities Exchange Act of 1934, as amended (the "Exchange Act") and interpretations thereof by the U.S. Securities and Exchange Commission ("SEC") in order to conduct business with Institutional Investors based in the U.S.,
MOSL has entered into a chaperoning agreement with a U.S. registered broker-dealer, Motilal Oswal Securities International Private Limited. ("MOSIPL"). Any business interaction pursuant to this report will have to be executed within the provisions of
this chaperoning agreement.
The Research Analysts contributing to the report may not be registered /qualified as research analyst with FINRA. Such research analyst may not be associated persons of the U.S. registered broker-dealer, MOSIPL, and therefore, may not be subject
to NASD rule 2711 and NYSE Rule 472 restrictions on communication with a subject company, public appearances and trading securities held by a research analyst account.
For Singapore
In Singapore, this report is being distributed by Motilal Oswal Capital Markets Singapore Pte Ltd (“MOCMSPL”) (Co.Reg. NO. 201129401Z) which is a holder of a capital markets services license and an exempt financial adviser in Singapore,
as per the approved agreement under Paragraph 9 of Third Schedule of Securities and Futures Act (CAP 289) and Paragraph 11 of First Schedule of Financial Advisors Act (CAP 110) provided to MOCMSPL by Monetary Authority of Singapore.
Persons in Singapore should contact MOCMSPL in respect of any matter arising from, or in connection with this report/publication/communication. This report is distributed solely to persons who qualify as “Institutional Investors”, of which some of
whom may consist of "accredited" institutional investors as defined in section 4A(1) of the Securities and Futures Act, Chapter 289 of Singapore (“the SFA”). Accordingly, if a Singapore person is not or ceases to be such an institutional investor, such
Singapore Person must immediately discontinue any use of this Report and inform MOCMSPL.
Disclaimer:
The report and information contained herein is strictly confidential and meant solely for the selected recipient and may not be altered in any way, transmitted to, copied or distributed, in part or in whole, to any other person or to the media or reproduced
in any form, without prior written consent. This report and information herein is solely for informational purpose and may not be used or considered as an offer document or solicitation of offer to buy or sell or subscribe for securities or other financial
instruments. Nothing in this report constitutes investment, legal, accounting and tax advice or a representation that any investment or strategy is suitable or appropriate to your specific circumstances. The securities discussed and opinions expressed in
this report may not be suitable for all investors, who must make their own investment decisions, based on their own investment objectives, financial positions and needs of specific recipient. This may not be taken in substitution for the exercise of
independent judgment by any recipient. Each recipient of this document should make such investigations as it deems necessary to arrive at an independent evaluation of an investment in the securities of companies referred to in this document
(including the merits and risks involved), and should consult its own advisors to determine the merits and risks of such an investment. The investment discussed or views expressed may not be suitable for all investors. Certain transactions -including
those involving futures, options, another derivative products as well as non-investment grade securities - involve substantial risk and are not suitable for all investors. No representation or warranty, express or implied, is made as to the accuracy,
completeness or fairness of the information and opinions contained in this document. The Disclosures of Interest Statement incorporated in this document is provided solely to enhance the transparency and should not be treated as endorsement of the
views expressed in the report. This information is subject to change without any prior notice. The Company reserves the right to make modifications and alternations to this statement as may be required from time to time without any prior approval.
MOSL, its associates, their directors and the employees may from time to time, effect or have effected an own account transaction in, or deal as principal or agent in or for the securities mentioned in this document. They may perform or seek to perform
investment banking or other services for, or solicit investment banking or other business from, any company referred to in this report. Each of these entities functions as a separate, distinct and independent of each other. The recipient should take this
into account before interpreting the document. This report has been prepared on the basis of information that is already available in publicly accessible media or developed through analysis of MOSL. The views expressed are those of the analyst, and
the Company may or may not subscribe to all the views expressed therein. This document is being supplied to you solely for your information and may not be reproduced, redistributed or passed on, directly or indirectly, to any other person or
published, copied, in whole or in part, for any purpose. This report is not directed or intended for distribution to, or use by, any person or entity who is a citizen or resident of or located in any locality, state, country or other jurisdiction, where such
distribution, publication, availability or use would be contrary to law, regulation or which would subject MOSL to any registration or licensing requirement within such jurisdiction. The securities described herein may or may not be eligible for sale in all
jurisdictions or to certain category of investors. Persons in whose possession this document may come are required to inform themselves of and to observe such restriction. Neither the Firm, not its directors, employees, agents or representatives shall
be liable for any damages whether direct or indirect, incidental, special or consequential including lost revenue or lost profits that may arise from or in connection with the use of the information.
The person accessing this information specifically agrees
to exempt MOSL or any of its affiliates or employees from, any and all responsibility/liability arising from such misuse and agrees not to hold MOSL or any of its affiliates or employees responsible for any such misuse and further agrees to hold MOSL
or any of its affiliates or employees free and harmless from all losses, costs, damages, expenses that may be suffered by the person accessing this information due to any errors and delays.
Registered Office Address: Motilal Oswal Tower, Rahimtullah Sayani Road, Opposite Parel ST Depot, Prabhadevi, Mumbai-400025; Tel No.: 022-3980 4263; www.motilaloswal.com. Correspondence Address: Palm Spring Centre, 2nd Floor, Palm
Court Complex, New Link Road, Malad (West), Mumbai- 400 064. Tel No: 022 3080 1000. Compliance Officer: Neeraj Agarwal, Email Id:
na@motilaloswal.com,
Contact No.:022-38281085.
Registration details of group entities.: MOSL: SEBI Registration: INZ000158836 (BSE/NSE/MCX/NCDEX); CDSL: IN-DP-16-2015; NSDL: IN-DP-NSDL-152-2000; Research Analyst: INH000000412. AMFI: ARN 17397. Investment Adviser:
INA000007100.IRDA Corporate Agent-CA0541. Motilal Oswal Asset Management Company Ltd. (MOAMC): PMS (Registration No.: INP000000670) offers PMS and Mutual Funds products. Motilal Oswal Wealth Management Ltd. (MOWML): PMS
(Registration No.: INP000004409) offers wealth management solutions. *Motilal Oswal Securities Ltd. is a distributor of Mutual Funds, PMS, Fixed Deposit, Bond, NCDs, Insurance and IPO products. * Motilal Oswal Commodities Broker Pvt. Ltd. offers
Commodities Products. * Motilal Oswal Real Estate Investment Advisors II Pvt. Ltd. offers Real Estate products. * Motilal Oswal Private Equity Investment Advisors Pvt. Ltd. offers Private Equity products
19 April 2018
8